You'll need to sign in to follow to this podcast.
New to Podcast Chart? Sign up.
Audio interviews with industry leaders and senior faculty with exclusive insights on current topics brought to you by [email protected]
January 19th, 2016
Episode 419 of 734 episodes
Biotech startups backed by corporate venture capitalists are much more likely to be successful at innovating than if they’re funded solely by independent VCs, says Mack senior fellow Gary Dushnitsky.
You'll need to sign in to write a comment.
Welcome to the daily audio workout for your head.
You'll need to sign in to add this to your collection.
Podcast Chart © 2017 Project Fantastic Ltd